Activity of daptomycin against Gram-positive bacterial isolates from Indian medical centres (2006–2007)
Authors:
- Dilip MathaiDMDilip Mathai
- Douglas J. BiedenbachDBDouglas J. Biedenbach
- Ronald N. JonesRJRonald N. Jones
- Jan M. BellJBJan M. Bell
- John TurnidgeJTJohn Turnidge
- Helio S. SaderHSHelio S. Sader
- 1 November 2009
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 34 (5) , 497-499
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008American Journal of Infection Control, 2008
- Clinical experience with daptomycin: bacteraemia and endocarditisJournal of Antimicrobial Chemotherapy, 2008
- Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetationsJournal of Antimicrobial Chemotherapy, 2008
- Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia–Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003–2004)International Journal of Antimicrobial Agents, 2007